首页|血红蛋白对未接受生物制剂治疗的复发性溃疡性结肠炎严重程度的预测价值

血红蛋白对未接受生物制剂治疗的复发性溃疡性结肠炎严重程度的预测价值

扫码查看
探讨血红蛋白对未接受生物制剂治疗的复发性溃疡性结肠炎严重程度的预测价值。回顾性分析医院收治的未接受生物制剂治疗的复发性溃疡性结肠炎(RUC)患者的临床资料,根据改良Mayo评分分为低风险组和高风险组,比较两组患者的基线资料,分析基线资料与RUC严重程度和改良Mayo评分的相关性,采用二元Logistic回归和线性回归模型评价RUC严重程度的预测因素,采用受试者工作特征(ROC)曲线评估RUC严重程度的预测因素。共纳入符合标准的RUC患者94例,其中男性54例(57。45%),平均年龄为(46。43±14。67)岁。高风险组29例(30。85%),低风险组65例(69。15%)。住院天数、改良Mayo评分、血红蛋白、血小板计数、C反应蛋白、血沉、D二聚体、纤维蛋白原和白蛋白水平在RUC不同风险分组之间存在统计学差异(P<0。05)。相关性分析显示:住院天数、血小板、C反应蛋白、血沉、D二聚体和纤维蛋白原与RUC严重程度和改良Mayo评分呈正相关(P<0。05),而血红蛋白和白蛋白与RUC严重程度和改良Mayo评分呈负相关(P<0。001)。二元Logistic回归分析显示:血红蛋白是RUC疾病严重程度的独立预测因素(P=0。003),线性回归分析表明血红蛋白和白蛋白是RUC患者改良Mayo评分的独立预测因素(P<0。05)。ROC分析所示,尽管血红蛋白、血沉、白蛋白、C反应蛋白、D二聚体、血小板计数和纤维蛋白原都能预测RUC的疾病严重程度,但是血红蛋白对其的诊断价值最高(AUC=0。879,P<0。001)。血红蛋白对未接受生物制剂治疗的复发性溃疡性结肠炎严重程度和改良Mayo评分具有中等强度的预测价值。
The Predictive Value of Hemoglobin in the Severity of Recurrent Ulcera-tive Colitis not Treated with Biological Agents
The objective of this study was to investigate the predictive value of hemoglobin in determining the severity of recurrent ulcerative colitis(RUC)in patients who were not treated with biologics.The methods involved a retrospective analysis of clinical data from RUC patients at the hospital who did not receive biological agents.Based on the modified Mayo score,the patients were catego-rized into low-risk and high-risk groups for comparison of baseline data.The correlation between baseline data and the severity of RUC,as indicated by the modified Mayo score,was then analyzed.Various statistical models,including binary logistic regression and linear regression,were employed to assess the predictors of RUC severity.The predictive value of these factors was further evaluated using receiver operating characteristic(ROC)curve analysis.A total of 94 RUC patients meeting the criteria were included,with 54 males(57.45%)and an average age of(46.43±14.67)years.There were 29 patients in the high-risk group(30.85%)and 65 in the low-risk group(69.15%).There were statistically significant differences in hospitalization days,modified Mayo score,hemo-globin,platelet count,C-reactive protein,erythrocyte sedimentation rate,D-dimer,fibrinogen,and albumin levels among different risk groups of RUC(P<0.05).Correlation analysis showed that hospitalization days,platelets,C-reactive protein,erythrocyte sedimenta-tion rate,D-dimer,and fibrinogen were positively correlated with the severity of RUC and modified Mayo score(P<0.05),while hemoglobin and albumin were negatively correlated with the severity of RUC and modified Mayo score(P<0.001).Binary logistic regression analysis indicated that hemoglobin was an independent predictor of the severity of RUC(P=0.003).Linear regression analysis showed that hemoglobin and albumin were independent predictors of the modified Mayo score in RUC patients(P<0.05).ROC analysis demonstrated that although hemoglobin,erythrocyte sedimentation rate,albumin,C-reactive protein,D-dimer,platelet count,and fibrinogen could all predict the severity of RUC,hemoglobin had the highest diagnostic value(AUC=0.879,P<0.001).In conclusion,hemoglobin exhibited moderate predictive value for determining the severity of RUC and modified Mayo score in patients not treated with biological agents.This study highlights the potential utility of hemoglobin as a prognostic marker in the management of recurrent ulcerative colitis.

Ulcerative colitisRecurrent ulcerative colitisDegree of disease activityHemoglobinModified Mayo scoreBiological agents

赵茗茗、乔晓、梁凤、叶彬、汪帅、吴莺

展开 >

淮安市第二人民医院消化内科,江苏淮安 223001

江苏大学附属医院消化内科,江苏镇江 212000

溃疡性结肠炎 复发性溃疡性结肠炎 疾病活动程度 血红蛋白 改良Mayo评分 生物制剂

2024

药物生物技术
中国药科大学,中国医药科技出版社,中国药学会

药物生物技术

CSTPCD
影响因子:0.463
ISSN:1005-8915
年,卷(期):2024.31(5)